KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】Cash flow
Market cap
¥428.3B
P/E ratio
38.9x
| 2015/03 | 2016/03 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 2,641 | 2,587 | 2,112 | 2,926 | 2,964 | 3,731 | 3,837 | 3,973 | 4,360 | 4,929 | 6,615 |
| Cash from operations | 15,445 | 14,329 | 16,097 | 22,350 | 20,007 | 20,089 | 23,986 | 22,419 | 31,914 | 18,360 | 11,246 |
| Capital expenditures | -3,100 | -3,381 | -2,850 | -2,841 | -3,419 | -4,379 | -3,795 | -3,663 | -14,747 | -12,756 | -26,056 |
| Cash from investing | -4,540 | -10,932 | -519 | 7,039 | -8,062 | -5,072 | -12,656 | 7,991 | -14,312 | -19,576 | -18,415 |
| Payments for dividends | -3,552 | -3,837 | -3,919 | -4,343 | -4,818 | -5,333 | -5,784 | -6,251 | -6,509 | -7,223 | -7,505 |
| Repurchases of common stock | -1,501 | -8,109 | -8,054 | -5,068 | - | -8,014 | - | -3,943 | -14,056 | -12,000 | - |
| Repayments of term debt | - | - | - | - | -1 | -570 | - | - | - | - | - |
| Cash from financing | -5,155 | -10,199 | -11,922 | -9,162 | -4,285 | -14,581 | -6,019 | -10,377 | -20,759 | -19,463 | -7,768 |